Trial Profile
A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- 14 Jun 2011 New trial record